Tanaka E - Search Results

1

Trimethadione tolerance test for the quantitative assessment of liver function in rats.

Ishikawa A, Fukao K, Tanaka E, Tsuji K, Osada A, Yamamoto Y, Kiyosawa T, Iwasaki Y. Ishikawa A, et al. Among authors: tanaka e. J Gastroenterol Hepatol. 1991 Jul-Aug;6(4):363-7. doi: 10.1111/j.1440-1746.1991.tb00872.x. J Gastroenterol Hepatol. 1991. PMID: 1912445

2

Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.

Abei M, Tanaka E, Tanaka N, Matsuzaki Y, Ikegami T, Ishikawa A, Osuga T. Abei M, et al. Among authors: tanaka n, tanaka e. J Gastroenterol. 1995 Aug;30(4):478-84. doi: 10.1007/BF02347564. J Gastroenterol. 1995. PMID: 7550858

3

Changes in caffeine, lidocaine and trimethadione metabolism in carbon tetrachloride-intoxicated rats as assessed by a "cocktail" study.

Tanaka E, Ishikawa A, Misawa S. Tanaka E, et al. Pharmacol Toxicol. 1994 Sep-Oct;75(3-4):150-3. doi: 10.1111/j.1600-0773.1994.tb00338.x. Pharmacol Toxicol. 1994. PMID: 7800655

4

Trimethadione metabolism as a probe drug to estimate hepatic oxidizing capacity in rats.

Tanaka E, Ishikawa A, Kobayashi S, Yasuhara H, Misawa S, Kuroiwa Y. Tanaka E, et al. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993 Feb;104(2):205-7. doi: 10.1016/0742-8413(93)90025-g. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993. PMID: 8098675 Review.

5

Trimethadione tolerance tests for the assessment of feasible size of hepatic resection in patients with hepatocellular carcinoma.

Ishikawa A, Fukao K, Tsuji K, Osada A, Yamamoto Y, Ohtsuka M, Tanaka E. Ishikawa A, et al. Among authors: tanaka e. J Gastroenterol Hepatol. 1993 Sep-Oct;8(5):426-32. doi: 10.1111/j.1440-1746.1993.tb01542.x. J Gastroenterol Hepatol. 1993. PMID: 8218989

6

Influence of partial hepatectomy in dogs on trimethadione metabolism and microsomal monooxygenases.

Tanaka E, Osada A, Ishikawa A, Nakamura T, Momose Y, Mikami T, Fukao K, Horie T. Tanaka E, et al. Xenobiotica. 1995 Dec;25(12):1301-10. doi: 10.3109/00498259509061919. Xenobiotica. 1995. PMID: 8719906

7

Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.

Tanaka E, Ishikawa A, Abei M, Kobayashi S. Tanaka E, et al. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Nov;115(3):211-6. doi: 10.1016/s0742-8413(96)00102-8. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996. PMID: 9375358 Review.

8

In vivo and in vitro trimethadione oxidation activity of the liver from various animal species including mouse, hamster, rat, rabbit, dog, monkey and human.

Tanaka E, Ishikawa A, Horie T. Tanaka E, et al. Hum Exp Toxicol. 1999 Jan;18(1):12-6. doi: 10.1177/096032719901800102. Hum Exp Toxicol. 1999. PMID: 10025363

9

The metabolism and excretion of trimethadione in patients with percutaneous transhepatic biliary drainage and renal dysfunction.

Tanaka E, Ishikawa A, Yamamoto Y, Fukao K, Iwasaki Y, Misawa S. Tanaka E, et al. J Pharmacobiodyn. 1989 Mar;12(3):145-8. doi: 10.1248/bpb1978.12.145. J Pharmacobiodyn. 1989. PMID: 2760794

10

Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.

Tanaka E, Ishikawa A, Ono A, Okamura T, Misawa S. Tanaka E, et al. J Pharmacobiodyn. 1987 Sep;10(9):499-502. doi: 10.1248/bpb1978.10.499. J Pharmacobiodyn. 1987. PMID: 2830397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,380 results

Search Page

Filters